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Introduction
Acne is a common skin condition with substantial cutaneous 
and psychological disease burden.1 Usually, it starts in 
adolescence and resolves by the mid-20s, but can continue 
up to 40 years of age in some people.2
 Active sebaceous glands and increased sebum production 
are implicated in the development of acne. Affected 
patients present with seborrhoea (greasy skin). There are 
comedones, papules, pustules and nodules in severe cases.
Discussion
The pathophysiology of acne involves increased sebum 
production, increased keratinisation of the pilosebaceous 
duct, proliferation of microbial flora like Propionibacterium 
acnes, Staphylococcus epidermidis and inflammation. 
P acnes is a normal component of the cutaneous flora which 
inhabits the pilosebaceous units and uses lipid-rich sebum 
as a nutrient source.1
Usually, acne in teenagers is caused by a hormonal 
imbalance that is associated with increased androgen 
levels at the onset of puberty. Genetic factors also influence 
susceptibility to acne. This is confirmed by the very high 
concordance between monozygotic twins, in which the 
extent and severity of acne and sebum excretion rate are 
virtually identical.2
Other secondary precipitators of acne include stress, the 
use of comedogenic cosmetics, drugs such as systemic 
steroids, endocrine diseases and polycystic ovarian 
syndrome.3 
Premenstrual flares occur in approximately 70% of females 
with acne. Possibly, this relates to premenstrual changes in 
the hydration of the pilosebaceous epithelium.4 Clinically, 
the lesions of acne are polymorphic. There may be open 
comedones (black heads) closed comedones (white heads), 
papules, pustules or in severe cases, nodules.4
Commonly, lesions occur on the face (in 99% of cases) and 
less so on the back (60%) and chest (15%).4 Itching is a rare 
symptom of acne, but may relate to the release of histamine-
like compounds by P.acnes. Pain may be associated with 
secondary infection of the lesions by other bacteria.  
It is important to grade acne according to severity before 
planning treatment.5 There are many acne-grading systems 
in existence, but there is no gold standard, nor standardised 
system, that is consistently used in clinical practice. Also, 
no method has yet gained universal acceptance.6,7
Acne can be graded on a scale of 1-10 as mild, moderate 
or severe.4 The other grading system is based on the 
morphology of lesions where mild acne consists of open 
and closed comedones and some papules and pustules. 
Moderate acne features more frequent papules and 
pustules with mild scarring. Severe disease contains all of 
the above, plus nodules and abscesses and more scarring.8 
(Figures 1-4).
The simplest way of grading acne is according to the 
predominant type of lesions that are present on the skin, 
regardless of number (Table I).5
Table I: Acne grading
Grade 1 Comedones only
Grade 2 Inflammatory papules in addition to comedones
Grade 3 Pustules that are present in addition to either of the 
above
Grade 4 Nodules, cysts, conglobate lesions or ulcers that are 
present in addition to any of the above
Acne has a psychosocial effect on sufferers. One study 
has shown that they experience shame, embarrassment, 
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anxiety, loss of self-esteem, impaired social contact and 
depression.9 Disease-specific questionnaires that are 
used to assess the psychosocial impact of acne include 
the Cardiff Acne Disability Index, Assessment of the 
Psychosocial Effects of Acne and the Acne Quality of Life 
Scale.10
Diet and acne
The role of diet in the development of acne is highly 
controversial. Patients and clinicians often suggest that 
fatty foods, sweets and chocolates are aggravating factors 
that cause acne, but previous older studies have failed to 
prove a causal relationship between diet and acne.4
However, more recent studies have demonstrated 
compelling evidence that high glycaemic-load diets may 
exacerbate acne.11  Some studies suggest that dairy intake 
increases acne risk.1 Further studies are needed to explore 
the effects of diet on acne.
Acne variants
There are several clinical variants of acne.  
Acne excorées
Acne excorées is a form of acne that results when patients 
pick at and tamper with the lesions. Such lesions become 
excoriated (Figure 5). Usually, there is an underlying 
personality issue, psychosocial problem or obsessive 
compulsive disorder in such patients.  
Figure 1: Mild acne vulgaris with papules and pustules
Figure 3: Severe acne with papules, pustules, nodules and abscesses
Figure 2: Moderate acne vulgaris
Figure 4: Acne with post-inflammatory hyperpigmentation
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Drug-induced acne
Drug-induced acne occurs following the intake of drugs 
such as corticosteroids, both orally and topically. The 
lesions of steroid-induced acne are more monomorphic. 
Antiepileptic drugs, like phenytoin and phenobarbitone; 
antituberculosis drugs, such as isoniazid and rifampicin; 
and halogens like iodides and halothane, can trigger acne 
or form acne eruptions. Other implicated drugs include 
lithium, quinine, sulphur and disulfiram.2
Acne cosmetica 
Acne cosmetica is caused by the use of comedogenic 
cosmetics. Characteristically, lesions occur in the perioral 
area in females, especially those who had acne as 
adolescents and who have used cosmetics for a long time.2
Pomade acne 
Pomade acne is due to the use of pomades. These are 
greasy preparations that are used to straighten curly hair. 
Lesions are noninflammed and occur on the forehead and 
other areas where greasy pomades may be in contact with 
hairless skin.
Chloracne 
Chloracne occurs following exposure to certain toxic 
chlorinated hydrocarbons. The lesions comprise multiple 
comedones on both sides of the face. The lesions may 
occur on other parts of the body in severe cases.2
Severe acne variants are pyoderma faciale, acne conglobata 
and acne fulminans.
Treatment
Treatment aims to alleviate symptoms, clear up existing 
lesions, limit disease activity, prevent the development of 
scars and improve quality of life.
The treatment of mild to moderate acne includes general 
measures, topical therapy, oral antibiotics and hormonal 
therapy.
Topical therapy alone may suffice in treating mild acne, 
while oral or topical therapies may be needed for moderate 
acne. Treatment of severe acne will not be dealt with in this 
article.
Topical therapies
The most commonly used topical therapies are benzoyl 
peroxide, topical retinoids, azelaic acid and topical 
antibiotics, either as monotherapy or in combination. 
Benzoyl peroxide is available in concentrations of 2.5%, 5% 
and 10%. It has antimicrobial activity, anti-inflammatory and 
keratinolytic activity.4  
Benzoyl peroxide eliminates both surface and ductal 
P. acnes by releasing oxygen into the anaerobic follicular 
micro-environment. Bacteria cannot develop resistance to 
this mode of action.12,13
Commonly used topical retinoids are isotretinoin 0.05% gel 
and adapalene 0.1% cream or gel. Topical retinoids have 
significant and rapid anti-inflammatory activity and can 
regulate follicular keratinisation as well.4,14  Retinoids are 
derivatives of vitamin A.  
There have been reports of teratogenicity in women who 
have used topical retinoids during early pregnancy. One 
study suggested a relative risk of 0.7 of having a baby with 
major congenital anomaly after using topical retinoids in 
pregnancy. Therefore, these products are better avoided 
during this time.8 
Topical antibiotics can also be used to treat mild to moderate 
acne. They include erythromycin and clindamycin, usually in a 
cream or lotion base.4 Topical antibiotics reduce colonisation 
by P. acnes and also have direct anti-inflammatory effects 
by way of antioxidant effects on leukocytes action. The 
resistance of P. acnes to erythromycin has been reported. 
This has reduced the usefulness of topical erythromycin in 
the treatment of acne.15
Topical azelaic acid is also useful in treating mild to 
moderate acne. It reduces comedones by normalising the 
disturbed terminal differentiation of keratinocytes in the 
follicle infundibulum.4 It also has an anti-inflammatory effect. 
According to the recommendations of the Global Alliance to 
Improve Outcomes in Acne, topical antibiotics should never 
be used as monotherapy in the treatment of acne.5
Oral antibiotics
Oral antibiotics, in combination with topical therapies such 
as retinoids and benzoyl peroxide, can be highly effective in 
treating acne. Oral antibiotics are indicated in patients with 
moderate to severe inflammatory acne, patients who do not 
improve on topical therapy alone, and patients whose acne 
covers a large surface area, thus making topical therapy 
Figure 5: Acne excorée. The patient squeezed the lesions, causing 
them to heal with scars
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impractical.16 Commonly used oral antibiotics are macrolides 
such as erythromycin and clindamycin; tetracyclines 
like doxycycline, minocycline and limecycline; as well as 
sulphonamides such as trimethoprim-sulfamethoxazole.
There are several important points to remember when 
prescribing these antibiotics. Oral erythromycin is safe in 
pregnancy, but erythromycin estolate should be avoided as 
it can cause cholestatic jaundice in pregnant patients. As an 
inhibitor of cytochrome P450, it can reduce the clearance 
of theophyllin, warfarin, carbamazepine and cyclosporine.  
Oral clindamycin may cause diarrhoea and may promote 
the overgrowth of Clostridium difficile in the gastrointestinal 
tract, causing pseudomembranous colitis.16  
Tetracyclines must be taken on an empty stomach (one 
hour before meals or two hours after meals), as ingestion 
with food, especially dairy products, can block the 
absorption of tetracyclines. Minocyline can cause a blue-
grey discoloration of the skin, especially on scars and sun-
exposed areas. It can also cross the blood-brain barrier, 
causing vestibular disturbances such as vertigo, dizziness 
and ataxia.  
Tetracyclines can inhibit skeletal growth in the foetus. 
Therefore, they should not be given to pregnant women, 
lactating mothers and children who are younger than nine 
years of age.16 
The Global Alliance to Improve Outcomes in Acne 
recommends a combination therapy of oral antibiotics, 
topical retinoids at night and benzoyl peroxide in the 
morning, for the treatment of mild to moderate acne.5 
It is recommended that oral antibiotics are given for a 
maximum of four months when they are used to treat acne. 
Treatment for longer periods results in antibiotic resistance.5 
After stopping antibiotics, maintenance therapy with topical 
retinoids and benzoyl peroxide should be continued to 
prevent relapses.
Hormonal therapy 
Hormonal therapy is used in female patients with mild to 
moderate acne to reduce seborrhoea and premenstrual 
flares. It is also useful in cases where the treatment of 
acne and contraception are needed concomitantly. It 
should be considered in female patients with acne that 
is refractory to oral antibiotic therapy too.4 Hormonal 
therapy for acne includes inhibitors of ovarian androgen 
production, such as the combined oral contraceptive (COC) 
pill that contains ethyniloestradiol and progesterone, as 
well as androgen receptor blockers, such as cyproterone 
acetate.4,17Antiandrogens suppress sebum production.4
COCs are often effective in treating mild forms of acne, but 
antiandrogens must be used5 for the more severe forms.
Progesterone-only contraceptives often worsen acne and 
should be avoided in women who have no contraindication 
to oestrogen-containing preparations.17 All hormonal 
therapies should be combined with appropriate topical 
therapies.4 Contraindications to the oral contraceptive pill 
include a family history or personal history of breast cancer, 
ovarian cancer, hypertension, venous thrombosis, smoking 
and other cardiac risk factors.15  
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